Shirley Clift
Overview
Explore the profile of Shirley Clift including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
215
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tani K, Azuma M, Nakazaki Y, Oyaizu N, Hase H, Ohata J, et al.
Mol Ther
. 2004 Sep;
10(4):799-816.
PMID: 15451464
We produced lethally irradiated retrovirally GM-CSF-transduced autologous renal tumor cell vaccines (GVAX) from six Japanese patients with stage IV renal cell cancer (RCC). Four patients received GVAX ranging from 1.4...
2.
Soiffer R, Hodi F, Haluska F, Jung K, Gillessen S, Singer S, et al.
J Clin Oncol
. 2003 Aug;
21(17):3343-50.
PMID: 12947071
Purpose: Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor (GM-CSF) by retroviral-mediated gene transfer generates potent antitumor immunity in patients with metastatic melanoma. Further clinical development...
3.
Salgia R, Lynch T, Skarin A, Lucca J, Lynch C, Jung K, et al.
J Clin Oncol
. 2003 Feb;
21(4):624-30.
PMID: 12586798
Purpose: We demonstrated that vaccination with irradiated tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulates potent, specific, and long-lasting antitumor immunity in multiple murine models and patients with...
4.
Kawai K, Tani K, Yamashita N, Tomikawa S, Eriguchi M, Fujime M, et al.
Int J Urol
. 2002 Sep;
9(8):462-6.
PMID: 12225344
A phase I study of granulocyte-macrophage colony-stimulating factor (GM-CSF) gene-transduced tumor vaccine for patients with metastatic renal cell carcinoma (RCC) was initiated in 1998, as the first cancer gene therapy...